![Researcher finds out why Levothyrox causes side effects](https://img.passeportsante.net/1000x526/2018-10-08/i86209-.jpeg)
October 8, 2018.
What if a chemical is causing the side effects of Levothyrox’s new formula? This is what a Toulouse scientist discovered, but the CNRS prohibited him from presenting the results of his research.
An impure element at the origin of the undesirable effects of Levothyrox?
The victims of the new Levothyrox have waited a long time for this news: there would therefore indeed be a scientific explanation for the side effects caused by their new treatment, which replaced, a few months ago, the drug they were taking against the dysregulation of their thyroid. According to information revealed by the Médiacités website, a researcher from the CNRS in Toulouse has found a chemical element that could be at the origin of the undesirable effects of the new formula of Levothyrox.
Jean-Christophe Garrigues, who works in the Laboratory of Molecular Interactions and Chemical and Photochemical Reactivity (IMRCP) at Paul Sabatier University in Toulouse, was mandated by the French Association of Thyroid Patients (AFMT) to conduct a survey on the components of the new formula of Levothyrox, in light of a report written last July by the National Medicines Safety Agency (ANSM).
CNRS researcher banned from press conference
However, by cross-checking his results with these data, the researcher realized that the ANSM had failed to notify the presence of a ” impure element […] in infinitesimal quantities ” which could totally disrupt the treatment, and cause nausea, fatigue, depression, hair loss and muscle pain.
Friday October 5, following these discoveries, Jean-Christophe Garrigues was to present the results of his investigations to the AFMT, however, the CNRS considered that its study had not been validated by the traditional evaluation process and that its results could not therefore be published as they stood. The researcher was therefore not allowed to present his results or to hold a press conference.
Gaelle Latour
Read also Many French people abandon their treatment for the thyroid